Tag: SOF-VAC
ASX biotech firm Noxopharm’s new mRNA enhancer to make vaccines safer
Australian biotech company Noxopharm Limited unveiled today the development of a new mRNA vaccine enhancer that will make mRNA vaccines safer by reducing inflammation associated with mRNA vaccines.Â
Featured Article
The future of sports manufacturing: Inside M2M Group’s AI-powered strategy
As the sports manufacturing industry evolves, artificial intelligence (AI) is emerging as a critical catalyst for innovation and efficiency.
